קנסידס 70 מג

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Kupi sada

Aktivni sastojci:

CASPOFUNGIN AS ACETATE

Dostupno od:

MERCK SHARP & DOHME ISRAEL LTD

ATC koda:

J02AX04

Farmaceutski oblik:

אבקה להכנת תמיסה מרוכזת לעירוי

Sastav:

CASPOFUNGIN AS ACETATE 70 MG/VIAL

Administracija rute:

תוך-ורידי

Tip recepta:

מרשם נדרש

Proizveden od:

LABORATORIES MERCK, SHARP & DOHME - CHIBRET, FRANCE

Terapijska grupa:

CASPOFUNGIN

Područje terapije:

CASPOFUNGIN

Terapijske indikacije:

Cancidas is indicated in adults and pediatric patients (3 months and older) for:- Empirical therapy for presumed fungal infections in febrile, neutropenic patients.- Treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. Cancidas has not been studied in endocarditis, ostemyelitis, and meningitis due to Candida.- Treatment of esophageal candidiasis.- Treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin B, lipid formulations of amphotericin B, and/or itraconazole). Cancidas has not been studied as initial therapy for invasive aspergillosis.

Proizvod sažetak:

התרופה תינתן לטיפול במקרים האלה: 1. אספרגילוזיס חודרני בחולים שנכשלו או שפיתחו אי סבילות באחד הטיפולים האחרים כגון: אמפוטריצין B, פורמולות ליפידיות של אמפוטריצין B או איטראקונאזול; 2. זיהומי קנדידה חודרניים קשים העמידים לטיפול ב-FLUCONAZOLE.

Datum autorizacije:

2011-11-30

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku engleski 17-08-2016
Svojstava lijeka Svojstava lijeka engleski 06-12-2016
Izvješće o ocjeni javnog Izvješće o ocjeni javnog engleski 20-01-2021

Upozorenja za pretraživanje vezana za ovaj proizvod

Pogledajte povijest dokumenata